NURECABSENURECA LIMITEDMediumNeutral
Announced Tue, 21 Jul · 16:50 IST

Nureca Q1 FY27 Investor Presentation: Revenue up 18% YoY, PAT at Rs 3.1 Cr

Mgmt Guided Margin ImprovementInvestor Communications View source PDF

NURECA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.8%1-day move
₹293.00
prior close
₹324.99
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.8-1.2-1.2-3.0+0.8+3.9+7.8
Up moveDown movePending
AI summary

Nureca posted Q1 FY27 revenue of Rs 40.3 Cr, up 18% YoY and 14% QoQ, its highest quarterly sales in 16 quarters. Operating profit rose to Rs 3.4 Cr (8.7% margin) from Rs 2.5 Cr in Q4 FY26. PBT was Rs 4.43 Cr with PAT at Rs 3.1 Cr versus a loss in Q4 FY26. Company remains debt-free with Rs 110 Cr in net cash and investments. Management highlighted focus on profitable growth, Punjab manufacturing expansion, and Dr Trust 360 app crossing 2 million users.

Likely market impact

Strong quarterly performance with improving margins, profitability turnaround, and a debt-free balance sheet with Rs 110 Cr net cash supportive of stock sentiment.